Transcatheter heart valves technologies

Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: an updated systematic review and meta-analysis

Published on 06/02/2025 | Yasmin Farah 1 et al. | Cardio-Oncology 2024; 10(1): 61 | 17 minute read

Abstract Clinical outcomes for TAVR in cancer survivors with prior chest radiation therapy (C-XRT) who develop symptomatic aortic-valve stenosis are

Transcatheter heart valves technologies

Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review

Published on 16/01/2025 | Joshua R. Hirsch 1 et al. | Catheterization and Cardiovascular Interventions 2025; AOP: 10.1002/ccd.31394 | 32 minute read

Abstract Transcatheter aortic valve replacement (TAVR) has become a viable treatment option for patients with severe aortic stenosis among all

Transcatheter heart valves technologies

Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report

Published on 16/01/2025 | Meng Xuyang 1 et al. | BMC Cardiovascular Disorders 2024; 24(1): 731 | 13 minute read

Abstract Background Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients

Transcatheter heart valves technologies

Anatomy of Risk: Decoding the Predictors of Vascular Access Complications in Transcatheter Aortic Valve Replacement

Published on 02/01/2025 | Hunter T. Row 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31397 | 13 minute read

Abstract Background Despite advancements in valve implantation devices, vascular access complications (VAC) remain a significant cause of morbidity and mortality

Transcatheter heart valves technologies

Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation

Published on 02/01/2025 | Danial Amoey 1 et al. | Cardiology and therapy 2024; 13(4): 761-73 | 19 minute read

Abstract Introduction Direct oral anticoagulant (DOAC) dose adjustment is based on age, renal function, and body weight. There is a

Transcatheter heart valves technologies

Transcatheter Aortic Valve Replacement: Full Unilateral Access Using the Ipsilateral Superficial Femoral Artery Is Effective

Published on 19/12/2024 | Duarte Cacela et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31341 | 18 minute read

Abstract Background Access site complications are very common complications in transcatheter aortic valve replacement (TAVR). Usually, a second arterial sheath

Transcatheter heart valves technologies

Comparison between Duke, ESC-2015, ISCVID-2023 and ESC-2023 criteria for the diagnosis of TAVR-related infective endocarditis

Published on 19/12/2024 | Inès Boufoula et al. | European heart journal cardiovascular Imaging 2024; aop: 10.1093/ehjci/jeae310 | 0 minute read

Transcatheter heart valves technologies

Transcatheter Tricuspid Valve Replacement Following Tricuspid Edge‐To‐Edge‐Repair

Published on 05/12/2024 | Andreas Goldschmied et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31317 | 8 minute read

Abstract Significant tricuspid regurgitation (TR) is seen as a relevant contributor of cardiac morbidity and mortality. Transcatheter tricuspid valve replacement

Transcatheter heart valves technologies

SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)

Published on 05/12/2024 | Paolisso Pasquale 1 et al. | Cardiovascular Diabetology 2024; 23(1): 420 | 24 minute read

Abstract Background A substantial number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) experience adverse

Transcatheter heart valves technologies

Association Between Direct Oral Anticoagulant Score and Bleeding Events in Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Cohort Study

Published on 21/11/2024 | YoshihiroHaranoMD 1 et al. | Journal of the American Heart Association 2024; 13(22): 036417 | 28 minute read

Abstract Background The Direct Oral Anticoagulant (DOAC) Score can predict bleeding risk in patients with atrial fibrillation taking DOACs; however,

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.